在美国中西部城市大型单中心患者人群中,恶性黑色素瘤和非黑色素瘤皮肤癌后诊断阿尔茨海默病的负相关关系
该研究基于美国中西部城市大型单中心电子病历数据库,纳入2001年1月至2015年12月期间年龄≥60且<89岁、随访至少1年、入组时无阿尔茨海默病、恶性黑色素瘤或非黑色素瘤皮肤癌诊断的患者,共82 925例。调整混杂因素后,恶性黑色素瘤、基底细胞癌和鳞状细胞癌患者后续发生阿尔茨海默病的风险均显著降低。
要点
- 恶性黑色素瘤患者后续阿尔茨海默病风险降低(OR 0.39,95%CI 0.16-0.96,P=0.042)。
- 基底细胞癌患者后续阿尔茨海默病风险降低(OR 0.18,95%CI 0.08-0.45,P<0.0001)。
- 鳞状细胞癌患者后续阿尔茨海默病风险降低(OR 0.08,95%CI 0.01-0.56,P=0.013)。
核心结论
- 这些发现为多种癌症患者阿尔茨海默病风险降低的日益增多的证据增添了新内容,并强调需要持续研究以阐明这种明显负相关可能背后的神经学和生物学机制。
研究设计与样本
- 大型城市、美国中西部、单中心电子病历数据仓库检索,检索时间为2001年1月至2015年12月。
- 纳入年龄≥60且<89岁、诊所随访至少1年、研究入组时无阿尔茨海默病、恶性黑色素瘤或非黑色素瘤皮肤癌诊断的患者。
- 共检测到82 925例已知种族和性别的患者数据。
- 恶性黑色素瘤和非黑色素瘤皮肤癌通过ICD-9和ICD-10编码检测,阿尔茨海默病新发诊断也通过ICD-9和ICD-10编码检测。
- 采用逻辑回归分析获得粗比值比和调整比值比。
主要发现
- 调整种族、性别、年龄、脑血管病、外周血管病和糖尿病等混杂因素后,恶性黑色素瘤患者后续阿尔茨海默病风险显著降低(OR 0.39,95%CI 0.16-0.96,P=0.042)。
- 调整后基底细胞癌患者后续阿尔茨海默病风险显著降低(OR 0.18,95%CI 0.08-0.45,P<0.0001)。
- 调整后鳞状细胞癌患者后续阿尔茨海默病风险显著降低(OR 0.08,95%CI 0.01-0.56,P=0.013)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although literature demonstrates a decreased risk of Alzheimer's disease (AD) in individuals with various cancers, including squamous cell cancers (SCC) and basal cell cancers (BCC) comprising non-melanoma skin cancers (NMSC), there is a paucity of literature to substantiate an association between malignant melanoma (MM) and AD. OBJECTIVE: The aim of this study was to determine whether an association exists between MM and AD as well as for NMSC and AD. METHODS: A large urban, Midwestern, US, single-centre, medical record (EMR) data repository was searched between January 2001 and December 2015, to identify all patients at age ≥60 and <89 years with a clinic follow-up of at least 1 year and no diagnosis for AD, MM or NMSC at the time of the study entry. Data collected included age, gender, race and duration of follow-up. MM and NMSC were detected by ICD-9 codes and ICD-10 codes. Incident diagnosis of AD was also detected by ICD-9 and ICD-10 codes. Logistic regression analysis was utilized to obtain crude and adjusted odds ratios (ORs). RESULTS: Data for a total of 82 925 patients with known race and gender and were detected. After adjusting for confounding factors (race, gender, age, cerebrovascular disease, peripheral vascular disease and diabetes), there was a significant decreased risk of subsequent AD in patients with MM (OR: 0.39; 95% CI: 0.16-0.96; P = 0.042) as well as in patients with BCC (OR: 0.18; 95% CI: 0.08-0.45; P < 0.0001) and for patients with SCC (OR: 0.08; 95% CI: 0.01-0.56; P = 0.013). CONCLUSION: These findings add to the growing body of evidence for a decreased risk of AD in patients with various cancers and highlight the need for ongoing research to elucidate both neurologic and biologic mechanisms that may underlie this apparent inverse association.
引用
- Ibler E, Tran G, Orrell KA, et al. Inverse association for diagnosis of Alzheimer's disease subsequent to both melanoma and non-melanoma skin cancers in a large, urban, single-centre, Midwestern US patient population. J Eur Acad Dermatol Venereol. 2018. PMID: 29573497. doi:10.1111/jdv.14952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。